Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Anesthesiology|December 22, 1999
Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholineR Miguel, T Witkowski, H Nagashima, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1973
Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in miceG P Khare, R W Sidwell, J T Witkowski, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1975
Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in miceR W Sidwell, L B Allen, J H Huffman, et al.
Journal of Molecular Biology|April 7, 1995
The zinc coordination site of the bacteriophage Mu translational activator protein, ComR T Witkowski, S Hattman, L Newman, et al.
Research Square|May 3, 2023
A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapyChao Ma, Huishu Wang, Lunan Liu, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid virusesJ H Huffman, R W Sidwell, G P Khare, et al.
Virus Research|May 5, 2019
Analysis of the integrin β3 receptor for pathogenic orthohantaviruses in rodent host speciesAlexander Müller, Alexandra Baumann, Sandra Essbauer, et al.
Science (New York, N.Y.)|August 25, 1972
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamideR W Sidwell, J H Huffman, G P Khare, et al.
Virology|April 9, 2016
Infection of human airway epithelial cells by different subtypes of Dobrava-Belgrade virus reveals gene expression patterns corresponding to their virulence potentialPeter T Witkowski, Daniel Bourquain, Katrin Bankov, et al.
Surgical Endoscopy|December 8, 2005
Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled studyE R Viscusi, S Goldstein, T Witkowski, et al.
Pageof 8